Klemen Strle, Ph.D.
Affiliations: | 2005 | University of Illinois, Urbana-Champaign, Urbana-Champaign, IL |
Area:
Molecular Biology, ImmunologyGoogle:
"Klemen Strle"Mean distance: 30533.1
Parents
Sign in to add mentorKeith W. Kelley | grad student | 2005 | UIUC | |
(Cytokine-induced IGF-I resistance in progenitor muscle cells.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Hernández SA, Ogrinc K, Korva M, et al. (2023) Association of Persistent Symptoms after Lyme Neuroborreliosis and Increased Levels of Interferon-α in Blood. Emerging Infectious Diseases. 29: 1091-1101 |
Jutras BL, Lochhead RB, Kloos ZA, et al. (2019) peptidoglycan is a persistent antigen in patients with Lyme arthritis. Proceedings of the National Academy of Sciences of the United States of America |
Lochhead RB, Ordoñez D, Arvikar SL, et al. (2018) Interferon-gamma production in Lyme arthritis synovial tissue promotes differentiation of fibroblast-like synoviocytes into immune effector cells. Cellular Microbiology. e12992 |
Sahay B, Bashant K, Nelson NJ, et al. (2018) Induction of IL-10 by Borrelia burgdorferi is regulated by the action of CD14-dependent p38-MAPK and cAMP-mediated chromatin remodeling. Infection and Immunity |
Miyabe C, Miyabe Y, Strle K, et al. (2016) An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy. Annals of the Rheumatic Diseases |
Crowley JT, Drouin EE, Pianta A, et al. (2015) A Highly Expressed Human Protein, Apolipoprotein B-100, Serves as an Autoantigen in a Subgroup of Patients with Lyme Disease. The Journal of Infectious Diseases |
Miyabe C, Strle K, Miyabe Y, et al. (2015) OP0273 Tocilizumab Enhances Regulatory T Cell Activation and Proliferation in Giant Cell Arteritis Annals of the Rheumatic Diseases. 74: 175.2-175 |
Londoño D, Cadavid D, Drouin EE, et al. (2014) Antibodies to endothelial cell growth factor and obliterative microvascular lesions in the synovium of patients with antibiotic-refractory lyme arthritis. Arthritis & Rheumatology (Hoboken, N.J.). 66: 2124-33 |
Strle K, Stupica D, Drouin EE, et al. (2014) Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 58: 372-80 |
Drouin EE, Seward RJ, Strle K, et al. (2013) A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease. Arthritis and Rheumatism. 65: 186-96 |